Abstract
The histopathologic features of 855 cervical biopsies were correlated with the presence of human papillomavirus DNA using in situ hybridization (ISH) with biotin labeled type specific probes for Human Papilloma Virus (HPV) types 6, 11, 16, 18, 31, 33 and 51. HPV-DNA was found in 18% (13/72) of cervical intraeptihelial neoplasia I (CIN I), 30% (35/115) of CIN II, 28% (57(206) of CIN III, in 84% (21/25) of flat condyloma and in 13% (15/112) of normal cervical tissue. HPV DNA was detectable in 11% (5/46) of cervical adenocarcinoma and in 21% (59/279) of squamous cell carcinoma (SCC) of the cervix. High risk HPV types were identified more often than low risk HPV types in CIN I, CIN II, CIN III and SCC. HPV type 16/18 predominates over HPV type 31/33/51 in CIN I, flat condyloma and in SCC. The prevalence of HPV was strongly associated with the grade of differentiation of SCC. It was identified in 59% (23/39) of well differentiated SCC, in 18% (25/142) of moderately differentiated and in 11% (11/98) of poorly differentiated SCC.
Similar content being viewed by others
References
Backe J, Mulfinger L, Ott M, Hillenbrand C, Roos T, Martius J (1996) Retrospective analysis of human papillomavirus DNA in cervical biopsies over ten years. Int J Fetomat Med: in press
Bernard C, Mougin C, Bettinger D, Didier JM, Lab M (1994) Detection of human papillomavirus by in situ polymerase chain reaction in paraffin-embedded cervical biopsies. Mol cell probes 8:337–343
Chapman WB, Lorincz AT, Willett GD, Wright VC, Kurman RJ (1993) Evaluation of two commercially available in situ hybridization Kits for detection of human papillomavirus DNA in cervical biopsies: comparison to Southern Blot hybridization. Mod Pathol 6:73–79
Chen TM, Chen CA, Wu CC, Huang SC, Hsieh CY (1994) The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int J Cancer 57:181–184
Collins JE, Jenkins D, McCance DJ (1988) Detection of human papillomavirus DNA sequences by in situ DNA-DNA hybridisation in cervical intraepithelial neoplasia and invasive carcinoma: a retrospective study. J Clin Pathol 41:289–295
Crum CP, Nuovo G, Friedman D, Silverstein SJ (1988) A comparison of biotin and isotopelabele ribonucleic acid probes for in situ detection of HPV-16 ribonucleic acid in genital precancers. Lab Invest 58:354–359
Duggan MA, Benoit JL, McGregor SE, Nation JG, Inoue M, Stuart GCE (1993) The human papillomavirus status of 114 endocervical adenocarcinoma cases by dot blot hybridization. Hum Pathol 24:121–125
Duggan MA, Inoue M, McGregor SE, Stuart GCE, Morris S, Chang-Poon V, Schepansky A, Honore L (1994) A paired comprison of dot blot hybridization and PCR amplification for HPV testing of cervical scrapes interpreted as CIN 1. Eur J Gynaec Oncol 15:178–187
ENZO Diagnostics PathoGene DNA Probe Assay for Detection of HPV (1988) Enzo Diagnostics, New York
Falcinelli C, Luzi P, Alberti P, Cosmi EV, Anceschi MM (1993) Human papilloma virus infection and Ki-ras oncogene in paraffin-embedded squamous carcinomas of the cervix. Gynecol Obstet Invest 36:185–188
Ferenczy A, Mitao M, Nagai N, Silverstein S, Crum CP (1985) Latent papillomavirus and recurring genital warts. N Engl J Med 313:784–788
Fukushima M, Okagaki T, Twiggs LB, Clark BA, Zachow KR, Ostrow RS, Faras AJ (1985) Histological types of carcinoma of the uterine cervix and the detectability of human papilomavirus DNA. Cancer Res 45:3252–3255
Griffin NR, Dockey D, Lewis FA (1991) Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization. Int J Gynecol Pathol 10:36–43
Heino P, Hukkanen V, Arstila V (1989) Detection of human papillomavirus (HPV) DNA in genital biopsy specimen by in situ hybridization with digoxigenin-labeled probes. J Virol Meth 26:331–338
Higgins DH, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ (1991) Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 338:910–913
Ikenberg H, Sauerbrei W, Schottmüller U, Spitz C, Pfleiderer A (1994) Human papilloma-virus DNA in cervical carcinoma-correlation with clinical data and influence on prognosis. Int J Cancer 59:322–326
Johnson K (1995) Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Can Med Assoc J 152:483–493
King L, Tase T, Twiggs LB, Okagaki T, Savage JE, Adcock LL, Prem KA, Carson LF (1989) Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix. Cancer 63:897–900
Kiviat NB, Koutsky LA, Critchlow CW, Galloway DA, Vernon DA, Peterson ML, McElhose PE, Pendras SJ, Stevens CE, Holmes KK (1990) Comparison of southern transfer hybridization and dot filter hybridization for detection of cervical human papillomavirus infection with types 6, 11, 16, 18, 31, 33 and 35. Am J Clin Pathol 94:561–565
Low SH, Thong TW, Ho TH, Lee Y-S, Morita T, Singh M, Yap EY, Chan YC (1990) Prevalence of human papillomavirus type 16 and 18 in cervical carcinomas: a study by dot and southern blot hybridization and the polymerase chain reaction. Jpn J Cancer Res 81:1118–1123
Lungu O, Sun XW, Wright TC, Ferenczy A, Richart R, Silverstein S (1995) A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet Gynecol 85:337–342
Meanwell CA, Cox MF, Blackledge G, Maitland NJ (1987) HPV 16 DNA in normal and malignant cervical epithelium: implication for the aetiology and behaviour of the cervical neoplasms. Lancet 1:703–707
Medas, Statistikprogramm für Medizin und Biowissenschaften, Grund C, Würzburg 1993
Munoz N, Bosch X, Kaldor JM (1988) Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer 57:1–5
Nielsen AL (1990) Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma. Cancer 65:2588–2593
Nuovo GJ (1988) Correlation of histology with human papillomavirus DNA detection in the female genital tract. Gynecol Oncol 31:176–181
Nuovo GJ (1989) A comparison of different methodologies (biotin based and 35S based) for the detection of human papillomavirus DNA. Lab Invest 61:471–476
Peng H, Liu S, Mann V, Rohan T, Rawls W (1991 Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in sichuan province, China. Int J Cancer 47:711–716
Reid R, Greenberg M, Jenson AB, Husain M, Willett J, Daoud Y, Temple G, Stanhope CR, Sherman AI, Phibbs GD, Lorincz AT (1987) Sexually transmitted papillomaviral infections: The anatomic distribution and pathologic grade of neoplastic lesions associated with differtient viral types. Am J Obstet Gynecol 156:212–222
Richart RM, Nuovo GJ (1990) Human papillomavirus DNA in situ hybridization may be used for the quality control of genital tract biopsies. Obstet Gynecol 75:223–226
Riou G, Favre M, Jeannel D, Bourhis J, le Doussal V, Orth G (1990) Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335:1171–1174
Rosai J (1989) Female reproductive system: uterus-cervix. In: Ackerman’s surgical Pathology, 7ed, Vol II, The C.V. Mosby Company, Washington, p 1028–1029
Schmauz R, Okong P, de Villiers EM, Dennin R, Brade L, Lwanga SK, Owor R (1989) Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 43:805–809
Schneider A, Oltersdorf T, Schneider V, Gissmann L (1987) Distribution pattern of human papilloma virus 16 genome in cervical neoplasia by molecular in situ hybridization of tissue sections. Int J Cancer 39:717–721
Schneider A, Kirchmayr R (1990) Spektrum von genitalen HPV-Infektionen und HPV-assoziierten Erkrankungen bei Frau und Mann. Geburtsh. und Frauenheilk. 50:518–523
Shroyer KR (1993) Human papillomavirus and endocervical adenocarcinoma. Human Pathol 24:119–120
Smotkin D, Berek JS, Fu YS, Hacker NF, Major FJ, Wettstein FO (1986) Human papillomavirus Deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol 68:241–244
Tase T, Okagaki T, Clark BA, Manias DA, Ostrow RS, Twiggs LB, Faras AJ (1988) Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. Cancer Res 48:993–998
Tsunokawa Y, Takebe N, Nozawa S (1986) Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. Int J Cancer 37:499–503
Vuopala S, Pöllänen R, Kauppila A, Lehto VP (1993) Detection and typing of human papillomavirus infection affecting the cervix, vagina and vulva. Arch Gynecol Obstet 253:75–83
Wilczinsky SP, Bergen S, Walker J, Liao SY, Pearlman LF (1988) Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Hum Pathol 19:697–704
World Health Organization (1992) Histopathologic classification of tumors and tumor-like lesions of the uterine cervix and vagina
Yokoyama M, Tsutsumi K, Pater A, Pater MM (1994) Human papillomavirus 18-immortalized endocervical cells with in vitro cytokeratin expression characteristics of adenocarcinoma. Obstet Gynecol 83:197–204
Zur Hausen H (1991) Human Papillomaviruses in the Pathogenesis of anogenital cancer. Virology 184:9–13
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Backe, J., Roos, T., Mulfinger, L. et al. Prevalence of human papillomavirus DNA in cervical tissue. Retrospective analysis of 855 cervical biopsies. Arch Gynecol Obstet 259, 69–77 (1997). https://doi.org/10.1007/BF02505312
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02505312